Institute of Medical Biology, A*STAR, Singapore, Singapore.
Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore, Singapore.
Nat Commun. 2021 Apr 9;12(1):2130. doi: 10.1038/s41467-021-22397-5.
Mito-SEPs are small open reading frame-encoded peptides that localize to the mitochondria to regulate metabolism. Motivated by an intriguing negative association between mito-SEPs and inflammation, here we screen for mito-SEPs that modify inflammatory outcomes and report a mito-SEP named "Modulator of cytochrome C oxidase during Inflammation" (MOCCI) that is upregulated during inflammation and infection to promote host-protective resolution. MOCCI, a paralog of the NDUFA4 subunit of cytochrome C oxidase (Complex IV), replaces NDUFA4 in Complex IV during inflammation to lower mitochondrial membrane potential and reduce ROS production, leading to cyto-protection and dampened immune response. The MOCCI transcript also generates miR-147b, which targets the NDUFA4 mRNA with similar immune dampening effects as MOCCI, but simultaneously enhances RIG-I/MDA-5-mediated viral immunity. Our work uncovers a dual-component pleiotropic regulation of host inflammation and immunity by MOCCI (C15ORF48) for safeguarding the host during infection and inflammation.
线粒体 SEPs 是小开放阅读框编码的肽,定位于线粒体以调节代谢。受线粒体 SEPs 与炎症之间存在有趣的负相关关系的启发,我们在这里筛选了能够改变炎症结果的线粒体 SEPs,并报告了一种名为“炎症期间细胞色素 C 氧化酶调节剂”(MOCCI)的线粒体 SEP,它在炎症和感染期间上调,以促进宿主保护性缓解。MOCCI 是细胞色素 C 氧化酶(复合物 IV)NDUFA4 亚基的同源物,在炎症期间替代复合物 IV 中的 NDUFA4,降低线粒体膜电位并减少 ROS 产生,从而导致细胞保护和免疫反应减弱。MOCCI 转录本还产生 miR-147b,其靶向 NDUFA4 mRNA,具有与 MOCCI 相似的免疫抑制作用,但同时增强 RIG-I/MDA-5 介导的病毒免疫。我们的工作揭示了 MOCCI(C15ORF48)对宿主炎症和免疫的双重多效性调节,以在感染和炎症期间保护宿主。